No Significant Growth Velocity Changes in Two Trials Evaluating the Potential Effects of Flunisolide HFA (AerospanTM) on Growth in Pediatric Patients with Mild-to-Moderate Asthma

No Significant Growth Velocity Changes in Two Trials Evaluating the Potential Effects of Flunisolide HFA (AerospanTM) on Growth in Pediatric Patients with Mild-to-Moderate Asthma

The second study was an open-label, randomized, 1-year safety study of flunisolide HFA, inhaled beclomethasone (BDP) CFC, and inhaled cromolyn (negative control) in children 4 to 11 with mild-to-moderate asthma (n=206).

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2016-02, Vol.137 (2), p.AB215-AB215
Hauptverfasser: Bensch, George W., MD, FAAAAI, Skoner, David P., MD
Format: Artikel
Sprache:eng
Schlagworte:
Allergy and Immunology
Asthma
Pediatrics
Velocity
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The second study was an open-label, randomized, 1-year safety study of flunisolide HFA, inhaled beclomethasone (BDP) CFC, and inhaled cromolyn (negative control) in children 4 to 11 with mild-to-moderate asthma (n=206).
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2015.12.1290